AgomAb Therapeutics NV · NASDAQ:AGMB

Epstein David R bought 15,000 AgomAb Therapeutics NV shares (Form 4)

Traded Nov 5, 2026 · Filed Nov 6, 2026

On Nov 5, 2026, Epstein David R (Director) bought 15,000 AgomAb Therapeutics NV shares at an average US$6.90 for US$104K, leaving 40,000 shares. Filed Nov 6, 2026 (Form 4).

Bought
15,000 shares
Price
US$6.90 average (US$6.81 to US$6.98)
Value
US$104K
Holding after
40,000 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 5, 2026Common sharesBuy5,000US$6.8130,000Direct
Nov 5, 2026Common sharesBuy5,000US$6.9135,000Direct
Nov 5, 2026Common sharesBuy5,000US$6.9840,000Direct

Source

Download original · View original at SEC

Related